Mr. Trent Northcutt reports

AURORA SPINE ANNOUNCES FULL RELEASE OF ITS SILO TFX MIS SACROILIAC JOINT FIXATION SYSTEM

Aurora Spine Corp. is in full commercial release of its proprietary SiLO TFX MIS (minimally invasive) sacroiliac (SI) joint fixation device system.

The patented, minimally invasive SiLO TFX MIS sacroiliac joint fixation system is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The SiLO TFX MIS sacroiliac joint fixation system includes a transfixing cone, an ilium screw, a sacrum screw and associated instrumentation. The SiLO TFX implants are designed to transfix the sacrum and ilium, providing stability for bony fusion.

Trent Northcutt, Aurora's president, chief executive officer and co-founder, stated, "We are excited to be in full launch of our game-changing treatment for patients suffering with SI joint pain and dysfunction."

Petra Lopizzo, Aurora's director of operations, said: "The release of SiLO TFX is proceeding smoothly and rapidly as we deploy more instruments sets and implants into the field. I am pleased with the teamwork between engineering, operations and marketing on the full release of the SiLO TFX system."

About Aurora Spine Corp.

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

We seek Safe Harbor.